|
METTL10 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.18790532965818E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.58300097661413E-11 |
| Normal-vs-Stage2 |
9.66209999999634E-05 |
| Normal-vs-Stage3 |
8.23859999998788E-07 |
| Normal-vs-Stage4 |
5.101300E-03 |
| Stage1-vs-Stage2 |
4.182000E-01 |
| Stage1-vs-Stage3 |
8.653200E-01 |
| Stage1-vs-Stage4 |
2.557000E-01 |
| Stage2-vs-Stage3 |
3.998800E-01 |
| Stage2-vs-Stage4 |
5.720200E-01 |
| Stage3-vs-Stage4 |
2.248600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.25626200950546E-12 |
| Normal-vs-AfricanAmerican |
8.29709999999872E-05 |
| Normal-vs-Asian |
2.915400E-03 |
| Caucasian-vs-AfricanAmerican |
3.057800E-03 |
| Caucasian-vs-Asian |
7.143000E-01 |
| AfricanAmerican-vs-Asian |
1.971000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.01579999967072E-08 |
| Normal-vs-Female |
1.278260E-03 |
| Male-vs-Female |
3.408000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.77619999994516E-07 |
| Normal-vs-Extreme_Weight |
7.26751991919627E-12 |
| Normal-vs-Obese |
4.45079999999987E-06 |
| Normal-vs-Extreme_Obese |
3.166100E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.103200E-01 |
| Normal_Weight-vs-Obese |
2.760800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.444000E-01 |
| Extreme_Weight-vs-Obese |
2.149700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.331600E-01 |
| Obese-vs-Extreme_Obese |
2.667600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.344400E-03 |
| Normal-vs-Age(41-60Yrs) |
6.63529999833656E-08 |
| Normal-vs-Age(61-80Yrs) |
3.67506025611419E-12 |
| Normal-vs-Age(81-100Yrs) |
2.60520000017195E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.244800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.119010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.208400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.893500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.284400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.627800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.66260347103753E-11 |
| Normal-VS-Type2 PRCC |
4.15656398189412E-12 |
| Normal-VS-KIRP CIMP |
1.045210E-01 |
| Normal-VS-Unclassified PRCC |
1.96722999999954E-05 |
| Type1 PRCC-VS-Type2 PRCC |
1.651160E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.238200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.814600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.899800E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.378030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.067650E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.81710005217906E-09 |
| Normal-vs-N1 |
6.167500E-04 |
| Normal-vs-N2 |
3.485600E-02 |
| N0-vs-N1 |
8.061600E-03 |
| N0-vs-N2 |
4.996000E-01 |
| N1-vs-N2 |
5.608600E-01 |
|
|
